Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Markets

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 12, 2022 9:39pm

150 Views

Post# 34680108

RE:RE:RE:RE:RE:Markets

You're right, I don't see us falling below 1.40 after said deal but I'm just not counting on a massive rally. Again, I hope I'm wrong.

MoneyMouth wrote: The one thing is that the valuation of the company within whatever deal will become a floor for the share price despite selling pressure. Just like the $1.20 of the cannacord deal became our floor last year.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles